Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma

European Journal of Haematology

Volumn 79, Issue 3, 2007, Pages 205-209

  Perry, Chava ^a   Herishanu, Yair ^a   Metzer, Ur ^a   Bairey, Osnat ^b   Ruchlemer, Rosa ^c   Trejo, Leonor ^a   Naparstek, Elizabeth ^a   Sapir, Einat Even ^a   Polliack, Aaron ^a,d  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c SHAARE ZEDEK MEDICAL CENTER   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

18FDG PET; CT PET; Extranodal lymphoma; Marginal zone lymphoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RELAPSE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; FEMALE; FOLLOW UP; GASTROSCOPY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STOMACH ULCER; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; DATA COLLECTION; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RECURRENCE; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 34547809362     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00895.x     Document Type: Article

References (13)

1. Elstrom R, Guan L, Baker G, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 2003 101 : 3875 6.
2. Kumar R, Maillard I, Schuster SJ, Alavi A. Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas. Radiol Clin North Am 2004 42 : 1083 100.
3. Friedberg JW, Chengazi V. PET scans in the staging of lymphoma: current status. Oncologist 2003 8 : 438 47.
4. Alinari L, Castellucci P, Elstrom R, et al. 18 F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. Leuk Lymphoma 2006 47 : 2096 101.
5. Jaffe ES, Harris NL, Stein HJWV. World Health Organization Classification of Tumours. Pathology & Genetics: Tumours of Haematopoietic and Lymphoid Tissues. Lyon : IARC Press, 2001.
6. Hoffmann M, Kletter K, Becherer A, Jager U, Chott A, Raderer M. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma. Oncology 2003 64 : 336 40.
7. Beal KP, Yeung HW, Yahalom J. FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases. Ann Oncol 2005 16 : 473 80.
8. von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: current applications and future directions. Radiology 2006 238 : 405 22.
9. Kostakoglu L, Hardoff R, Mirtcheva R, Goldsmith SJ. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics 2004 24 : 1411 31.
10. Israel O, Yefremov N, Bar-Shalom R, et al. PET/CT detection of unexpected gastrointestinal foci of 18 F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med 2005 46 : 758 62.
11. Hicks RJ, Mac Manus MP, Seymour JF. Initial staging of lymphoma with positron emission tomography and computed tomography. Semin Nucl Med 2005 35 : 165 75.
12. Kasamon YL, Jones RJ, Wahl RL. Integrating PET and PET/CT into the risk-adapted therapy of lymphoma. J Nucl Med 2007 48 (Suppl. 1 19S 27S.
13. Schoder H, Noy A, Gonen M, et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. J Clin Oncol 2005 23 : 4643 51.